ClinicalTrials.govpublic full text
A First-in-Human Study of Single and Multiple Doses of anle138b in Healthy Subjects
healthy volunteers, anle138b, alpha-synuclein, oligomer modulator, parkinson disease, multiple system atrophy, neurodegenerative diseases, alzheimer disease, tauopathies, amyloid, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 915008
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.